The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Update on gout: new therapeutic strategies and options
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
A pilot study of IL-1 inhibition by anakinra in acute gout
So, A., De Smedt, T., Revaz, S., & Tschopp, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2143 · Cited by 727
Dehghan, A., Köttgen, A., Yang, Q., Hwang, S.-J., Kao, W. L., Rivadeneira, F., Boerwinkle, E., Levy, D., Hofman, A., Astor, B. C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61343-4 · Cited by 718
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Woodward, O. M., Köttgen, A., Coresh, J., Boerwinkle, E., Guggino, W. B., & Köttgen, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901249106 · Cited by 688
Schumacher, H. R., Becker, M. A., Wortmann, R. L., MacDonald, P. A., Hunt, B., Streit, J., Lademacher, C., & Joseph‐Ridge, N. (2008) · Arthritis Care & Research · doi:10.1002/art.24209 · Cited by 638
Comparison of drug adherence rates among patients with seven different medical conditions
Briesacher, B. A., Andrade, S. E., Fouayzi, H., & Chan, K. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.4.437 · Cited by 587
Terkeltaub, R. A., Furst, D. E., Bennett, K., Kook, K. A., Crockett, R. S., & Davis, M. W. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27327 · Cited by 536
Self-citationTerkeltaub, R. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp030733 · Cited by 456
Self-citationEffect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic gout
Perez‐Ruiz, F., Calabozo, M., Pijoan, J. I., Herrero‐Beites, A. M., & Ruibal, A. (2002) · Arthritis Care & Research · doi:10.1002/art.10511 · Cited by 454
Wallace, K. L., Riedel, A. A., Joseph‐Ridge, N., & Wortmann, R. L. (2004) · PubMed · Cited by 426
Liu‐Bryan, R., Scott, P., Sydlaske, A., Rose, D. M., & Terkeltaub, R. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21238 · Cited by 414
Self-citationMutations in Glucose Transporter 9 Gene SLC2A9 Cause Renal Hypouricemia
Matsuo, H., Chiba, T., Nagamori, S., Nakayama, A., Domoto, H., Phetdee, K., Wiriyasermkul, P., Kikuchi, Y., Oda, T., Nishiyama, J., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.11.001 · Cited by 389
Anzai, N., Ichida, K., Jutabha, P., Kimura, T., Babu, E., Jin, C. J., Srivastava, S., Kitamura, K., Hisatome, I., Endou, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800156200 · Cited by 359
Dual energy computed tomography in tophaceous gout
Choi, H. K., Al-Arfaj, A. M., Eftekhari, A., Munk, P. L., Shojania, K., Reid, G., & Nicolaou, S. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.099713 · Cited by 330
Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.
Borstad, G. C., Bryant, L. R., Abel, M. P., Scroggie, D. A., Harris, M. D., & Alloway, J. A. (2004) · PubMed · Cited by 328
Long-term Cardiovascular Mortality Among Middle-aged Men With Gout
Krishnan, E. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.10.1104 · Cited by 328
Janssens, H. J., Janssen, M., van de Lisdonk, E. H., van Riel, P. L., & van Weel, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60799-0 · Cited by 317
Wortmann, R. L. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200205000-00015 · Cited by 304
Terkeltaub, R., Sundy, J. S., Schumacher, H. R., Murphy, F., Bookbinder, S., Biedermann, S., Wu, R., Mellis, S., & Radin, A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108936 · Cited by 300
Self-citationTerkeltaub, R. A. (2009) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.006 · Cited by 299
Self-citationSarawate, C. A., Brewer, K. K., Yang, W., Patel, P. A., Schumacher, H. R., Saag, K. G., & Bakst, A. W. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.7.925 · Cited by 292
Perez-Ruiz, F., Alonso-Ruiz, A., Calabozo, M., Herrero-Beites, A., García-Erauskin, G., & Ruiz-Lucea, E. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.9.545 · Cited by 257
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
Schumacher, H. R., Becker, M. A., Lloyd, E., MacDonald, P. A., & Lademacher, C. (2008) · Rheumatology · doi:10.1093/rheumatology/ken457 · Cited by 251
Zharikov, S., Krotova, K., Hu, H., Baylis, C., Johnson, R. J., Block, E. R., & Patel, J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00075.2008 · Cited by 239
Singh, J. A., & Strand, V (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081604 · Cited by 226
The inflammatory process of gout and its treatment.
Cronstein, B. N., & Terkeltaub, R. A. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1908 · Cited by 216
Self-citationMechanisms of inflammation in gout
Dalbeth, N., & Haskard, D. O. (2005) · Rheumatology · doi:10.1093/rheumatology/keh640 · Cited by 210
Reinders, M. K., Haagsma, C., Jansen, T. L. T. A., van Roon, E. N., Delsing, J., van de Laar, M. A. F. J., & Brouwers, J. R. B. J. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091462 · Cited by 191
Rubin, B. R., Burton, R., Navarra, S., Antigua, J., Londoño, J., Pryhuber, K. G., Lund, M., Chen, E., Najarian, D. K., Petruschke, R. A., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20007 · Cited by 188
Quality of Life and Disability in Patients with Treatment-Failure Gout
BECKER, M. A., SCHUMACHER, H. R., BENJAMIN, K. L., GOREVIC, P., GREENWALD, M., FESSEL, J., EDWARDS, L., KAWATA, A. K., FRANK, L., WALTRIP, R., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.071229 · Cited by 187
Adherence with urate-lowering therapies for the treatment of gout
Harrold, L. R., Andrade, S. E., Briesacher, B. A., Raebel, M. A., Fouayzi, H., Yood, R. A., & Ockene, I. S. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2659 · Cited by 181
Gout: On the brink of novel therapeutic options for an ancient disease
Bieber, J. D., & Terkeltaub, R. A. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20438 · Cited by 181
Self-citationSundy, J. S., Becker, M. A., Baraf, H. S. B., Barkhuizen, A., Moreland, L. W., Huang, W., Waltrip, R. W., Maroli, A. N., Horowitz, Z., & Pegloticase Phase 2 Study Investigators (2008) · Arthritis & Rheumatism · doi:10.1002/art.23810 · Cited by 181
Man, C. Y., Cheung, I. T. F., Cameron, P. A., & Rainer, T. H. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.11.014 · Cited by 177
Dalbeth, N., & Stamp, L. K. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00270.x · Cited by 153
Lowering serum uric acid levels: What is the optimal target for improving clinical outcomes in gout?
Pérez-Ruiz, F., & Lioté, F. (2007) · Arthritis Care & Research · doi:10.1002/art.23007 · Cited by 148
Neogi, T., Hunter, D. J., Chaisson, C. E., Allensworth‐Davies, D., & Zhang, Y. (2006) · PubMed · Cited by 127
A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout
Chao, J., & Terkeltaub, R. A. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0019-z · Cited by 115
Self-citationKloss‐Brandstätter, A., Kiechl, S. J., Kollerits, B., Hunt, S. C., Heid, I. M., Coassin, S., Willeit, J., Adams, T. D., Illig, T., Hopkins, P. N., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0349 · Cited by 114
Disease-Related and All-Cause Health Care Costs of Elderly Patients With Gout
Wu, E. Q., Patel, P., Yu, A. P., et al. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.2.164 · Cited by 112
Gout. Novel therapies for treatment of gout and hyperuricemia
Terkeltaub, R. A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2738 · Cited by 91
Self-citationReinders, M. K., van Roon, E. N., Houtman, P. M., Brouwers, J. R. B. J., & Jansen, T. (2007) · Clinical Rheumatology · doi:10.1007/s10067-006-0528-3 · Cited by 89
Melanocortin 3 receptors control crystal‐induced inflammation
Getting, S. J., Lam, C. W., Chen, A. S., Grieco, P., & Perretti, M. (2006) · The FASEB Journal · doi:10.1096/fj.06-6339com · Cited by 74
Quality of life and quality of care for patients with gout
Singh, J. A. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0022-4 · Cited by 73
Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout
Urano, W., Taniguchi, A., Anzai, N., Inoue, E., Kanai, Y., Yamanaka, M., Endou, H., Kamatani, N., & Yamanaka, H. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.106856 · Cited by 68
Hak, A. E., & Choi, H. K. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f524a2 · Cited by 64
Liebman, S. E., Taylor, J. G., & Bushinsky, D. A. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0040-z · Cited by 61
Treatment‐failure gout: A moving target
Edwards, N. L. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23803 · Cited by 57
Uricase and other novel agents for the management of patients with treatment-failure gout
Sundy, J. S., & Hershfield, M. S. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0041-y · Cited by 47
Measuring quality of care for rheumatic diseases using an electronic medical record
Agnew-Blais, J., Coblyn, J., Katz, J. N., Anderson, R. J., Mehta, J., & Solomon, D. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089318 · Cited by 23
Quality of care in gout: from measurement to improvement.
Mikuls, T. R. (2007) · PubMed · Cited by 19
Cited by
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
Self-citationA laser-engraved wearable sensor for sensitive detection of uric acid and tyrosine in sweat
Yang, Y., Song, Y., Bo, X., Min, J., Pak, O. S., Zhu, L., Wang, M., Tu, J., Kogan, A., Zhang, H., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0321-x · Cited by 1,270
SLC Transporters as Therapeutic Targets: Emerging Opportunities
Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835
Metadata
- Authors
- Terkeltaub, R.
- Venue
- Nature Reviews Rheumatology
- Published
- 2010-01
- Volume
- 6
- Issue
- 1
- Pages
- 30-38
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2021110479
- Cited by
- 387
- References
- 56
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.